explore
Previous article:
Medical leaders decry Supreme Court decision on affirmative action
Next article: A letter from the executive editor: The 2023 STATUS List
Next article: A letter from the executive editor: The 2023 STATUS List
knowledge
leisure time
-
The biotech scorecard for Q3: 15 stock
2025-10-02 22:38 -
Biogen’s boardroom scandal saddles CEO with first crisis
2025-10-02 22:34 -
AstraZeneca lung cancer study comes in below expectations
2025-10-02 22:13 -
Biden administration begins canceling student loan debt for 804,000 borrowers
2025-10-02 21:56 -
Senators push IRS to launch nonprofit hospital probe
2025-10-02 20:57 -
The biotech scorecard for Q3: 15 stock
2025-10-02 20:13